InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Federal Circuit vacates injunction in Amgen’s dispute with Sanofi

Michael Loney, New York


The permanent injunction granted by the District of Delaware in the dispute between Amgen and Sanofi/Regeneron over cholesterol-lowering treatment has been vacated, in a decision that also included some implications for the USPTO’s practice of granting broad antibody claims

The Federal Circuit has vacated the permanent injunction in the dispute between Amgen and Sanofi/Regeneron over cholesterol-lowering treatment.

Sanofi and Regeneron Pharmaceuticals appealed a final judgment of the District of Delaware in January that held that two patents were...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null

null null null

null null null

Mid Year 2018

PTAB practice in a post-SAS world

The big questions remaining after the Supreme Court’s SAS ruling include how institution rates will change, how strategy at the Board should evolve, and how district courts and the Federal Circuit will react. Michael Loney investigates



Most read articles

Supplements